01863nam a2200349 a 4500001001200000003000800012006001900020007001500039008004100054010001700095020003100112020001800143040002100161035002100182050002500203082001700228100002100245245011800266260006400384300001100448504005100459505056000510533015201070650002601222650002701248650002501275655002901300700002401329710001701353856012601370999001701496ebr10297756CaPaEBRm        u        cr cn|||||||||070610s2007    enk     sb    001 0 eng d  z  2007024176  z9780470319383 (alk. paper)  z9780470518144  aCaPaEBRcCaPaEBR  a(OCoLC)60999729414aRC694.3b.A77 2007eb04a616.1/422221 aAskari, Arman T.10aManagement strategies in antithrombotic therapyh[electronic resource] /cby Arman Askari and Adrian W. Messerli.  aChichester ;aHoboken, N.J. :bJohn Wiley and Sons,cc2007.  a350 p.  aIncludes bibliographical references and index.0 aThrombosis and antithrombotics in vascular disease -- Aspirin -- Thienopyridines, ticlopidine, and clopidogrel -- Platelet glycoprotein IIb/IIIa inhibitors -- Unfractionated heparin -- Low-molecular-weight heparins -- Direct thrombin inhibitors -- Fibrinolytic agents -- Acute ST-segment elevation myocardial infarction -- Acute coronary syndromes / non-ST-segment elevation myocardial infarction -- Anticoagulation strategies for patients undergoing percutaneous coronary intervention -- Venous thromboembolic disease -- Heparin-induced thrombocytopenia.  aElectronic reproduction.bPalo Alto, Calif. :cebrary,d2009.nAvailable via World Wide Web.nAccess may be limited to ebrary affiliated libraries. 0aThrombolytic therapy. 0aThrombosisxTreatment. 0aFibrinolytic agents. 7aElectronic books.2local1 aMesserli, Adrian W.2 aebrary, Inc.40uhttp://site.ebrary.com/lib/rucke/Doc?id=10297756zAn electronic book accessible through the World Wide Web; click to view  c63846d63846